on THERACLION (EPA:ALTHE)
Theraclion Announces Changes in Board Leadership
Malakoff-based medical technology company, Theraclion, announces a significant evolution in its Board of Directors. Yann Duchesne has stepped down from his roles as Director and Chairman, positions he held since January 2022. The decision follows the company's General Meeting held on June 18, 2026.
Theraclion expresses gratitude to Mr. Duchesne for his contributions. In response, the company's shareholders approved a new Board consisting of Lijuan Deng, Claude Lenoir, Cédric Bellanger, Mehdi El Glaoui, and Vincent Gardès. Mr. Gardès recently served as an observer before joining the Board officially.
Claude Lenoir has been appointed as Interim Chairman, ensuring continued governance stability. CEO Martin Deterre highlighted Mr. Duchesne's significant influence on the company's strategic direction and is optimistic about Theraclion's future leadership.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all THERACLION news